Parkinson’s disease research at UCL gets £19m boost

Parkinson's disease researchers at UCL are launching three new studies to understand causes and progression of the disease, with the aim of finding new approaches to treatment. The studies are among 21 international projects receiving new funding from the Aligning Science Across Parkinson's (ASAP) initiative. ASAP is partnering with The Michael J. Fox Foundation for Parkinson's Research to implement its programs and issue these grants. Parkinson's disease is a progressive condition of brain degeneration resulting in tremors, stiffness, slowness of movement and other symptoms. Currently there are no reliable measures to track Parkinson's progression in the brain, so clinicians rely on monitoring symptoms. Treatments can alleviate the symptoms, but do not slow the progression of the disease. One study will be investigating whether gut bacteria may contribute to causing Parkinson's disease.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience